# An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus

> **NCT00875108** · PHASE3 · COMPLETED · sponsor: **Biodel** · enrollment: 116 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** VIAject™

## Key facts

- **NCT ID:** NCT00875108
- **Lead sponsor:** Biodel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875108, "An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00875108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*